Two Australian regulatory frameworks are fundamental to the cultivation of genome edited plants and marketing of their products. These are the gene technology and food regulatory frameworks. Both frameworks rely on process triggers—that process being the use of gene technology. Unfortunately, these frameworks use different definitions of gene technology, creating the likelihood of different responses to genome edited plants, particularly to plants produced using SDN-2 or ODM.
No genome edited plants are currently cultivated in Australia but the relevant regulators are each currently undertaking reviews to determine whether some or all genome editing techniques are gene technology and how their frameworks should respond to those techniques. Final decisions are expected during 2018. In the meantime, the regulators have each adopted interim approaches to genome edited plants or their products, summarised in the first table.
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
The frameworks differ in regards to responsibility for monitoring and enforcement. Monitoring and enforcement of the food regulatory regime is carried out by the states (and local governments in some states); with respect to the agvet chemicals framework, national responsibility continues until the point of sale, when responsibility reverts to the states/territories; federal officers are responsible for monitoring and enforcement of the gene technology regime.
Environment Protection and Biodiversity Conservation Act 1999 (Cth). An example of such state legislation is the Environmental Protection Act 1970 (Vic).
Australia had a voluntary self-regulatory system for GM research from the mid-1970s until the introduction of the gene technology regulatory framework.
Although only in New South Wales and Northern Territory are amendments to the federal legislation automatically adopted into state mirroring legislation. In the other jurisdictions, periods of legislative inconsistency (and uncertainty), occur as each jurisdiction arranges for the passage of new amendments to the federal legislation. Productivity Commission (2016), p. 281.
Gene Technology Act 2000 (Cth) s 5. The state and territory governments also agreed to maintain legislation that corresponds with the Commonwealth Gene Technology Act under the inter-governmental Gene Technology Agreement 2001. Nevertheless, there are differences in the corresponding mirroring legislation.
There are two additional avenues to authorisation but these are exceptional. These are licenses for inadvertent dealings, pursuant to which the GTR can grant a licence to enable the disposal of a GMO inadvertently present on the applicant’s land; and an Emergency Dealing Determination (EDD) which is a legislative instrument made by the Minister under section 72 of the Act to expedite approval of dealings with a GMO in an emergency. This was introduced during the 2007 outbreak of equine influenza, to enable the import of a vaccine. Four inadvertent dealings licences were issued in 2016–2017 following the unknowing importation of GM petunias which had not been authorised under the regulatory framework, to allow all plants and seeds to be disposed of.
The legislation explains that ‘a dealing with a GMO involves the intentional release of the GMO into the environment if the GMO is intentionally released into the open environment, whether or not it is released with provision for limiting the dissemination or persistence of the GMO or its genetic material in the environment.’ Gene Technology Act 2000 (Cth) s 11.
‘Organism’ is defined in the GT Act as ‘any biological entity that is: (a) viable; or (b) capable of reproduction; or (c) capable of transferring genetic material’. Gene Technology Act 2000 (Cth) s 10(1), definition of ‘organism’.
While the definitions in the legislation have not been amended since their introduction in 2000, the Regulations (and the Schedules that list the exclusions from those definitions) were amended in 2006. These changes resulted in the provisions described here. The original version of reg. 4 listed only somatic cell nuclear transfer (cloning) as being excluded from gene technology and there was no schedule of other exclusions. The 2006 amendments replaced reg. 4 with the current reference to techniques listed in Sch. 1A, that Schedule also being added at that time. The further amendments in 2011 to Sch. 1 are not relevant here.
Despite finding there was no intrinsic difference between GM food and other food produced using random breeding practices, the Australian food regulator nevertheless recommended that GM food should be specifically authorised before use for food. At that time, there was no monitoring of any new food products regardless of how they were produced. That has now been changed by the addition of a novel foods standard.
Gene Technology Act 2000 (Cth) s 43(3). This is 90 business days for DNIR, 180 for a DIR licence for limited and controlled release (i.e. field trial) and 255 for a DIR licence for commercial release. A longer period is established where a significant risk is identified. Gene Technology Regulations reg 8. Note that the statutory timeframe clock can be stopped where the GTR seeks more information. Applications for accreditation and certification also have time-frames set by the regulations.
Certification occurs pursuant to Gene Technology Act 2000 (Cth) s 84. Classification relates to structural integrity of buildings and equipment, and to handling practices used by people working in the facility. Australian Department of Health (2017), p. 33.
Food Standards Australia New Zealand Act 1991 (Cth) s 13. Division 1 of Part 3 of the FSANZ Act specifies that the Authority may accept applications for the development or variation of food regulatory measures, including standards. This Division also stipulates the procedure for considering an application for the development or variation of food regulatory measures.
The Food Regulation Standing Committee’s Implementation Sub-Committee [now known as the Implementation Subcommittee for Food Regulation] has formed an Expert Advisory Group (EAG), involving laboratory personnel and representatives of the Australian and New Zealand jurisdictions, to identify and evaluate appropriate methods of analysis associated with all applications to FSANZ, including those applications for food produced using gene technology. FSANZ (2017), p. 6. 20 December 2017 [35-17] Call for Submissions – Application A1154. Food derived from insect-protected cotton line MON88702.
Australian Department of Health (2017), p. 60. This is required pursuant to the Gene Technology Agreement between the national and state/territory governments, clause 44.
The OGTR received 741 submissions, 615 of which were received through a form on a website initiated by Friends of the Earth Australia. Australian Department of Health (2017), pp. 60–61. The submissions are available on the OGTR website.
OGTR (2017a), p. 11. The GTR notes that there are two organisms excluded through item 1 that cannot take advantage of the proposed approach and will therefore be unintentionally reclassified as GMOs if item 1 is deleted. These are NoGall (Agrobacterium radiobacter strain K1026) and VaxSafe PM (Pasteurella multicida strain PMP1). It is proposed that they will be specifically listed in Sch 1 items 10 and 11 to ensure they continue to be excluded from regulation. OGTR (2017a), p. 11.
OGTR (2017a), p. 10 citing Gene Technology Regulations Regulation Impact Statement Section 4 part (a), discussion of listing a limited class of organisms as not being GMOs, published as part of the 2001 Explanatory Statement.
As the Consultation Paper explains ‘While the Regulator can undertake reviews of the Regulations to improve the clarity of definitions and practices, any change in approach to what is to be regulated or not can only be done by the owners of the policy setting for the Scheme.’ OGTR (2017b), p. 12.
OGTR (2017b), p. 16. As in the 2011 review of the GT Regulations, the Consultation Paper notes that the complex and lengthy process for amending the regulatory framework challenges governance and needs to be overhauled.
To clarify that these new techniques were not deregulated (and correct a drafting error identified by the High Court) the Regulations were amended by deleting from regulation 3(1)(b) ‘or chemical or radiation treatments that cause changes in chromosome number or cause chromosome rearrangements’ and inserting new regulation 3(1)(ba) ‘organisms that result from mutagenesis that uses chemical or radiation treatments that were in use on or before 29 July 1998’.
Australia New Zealand Food Standards Code Standard 1.2.1—Requirements to have labels or otherwise provide information. See also Standard 1.5.2—Food Produced Using Gene Technology.
Gene Technology Act 2000 (Cth) ss 32–38. The penalties for dealing without a licence and for breach of licence conditions include up to two years imprisonment, fines of up to $55,000 for an individual and from $275,000 for a corporation.
The penalties for aggravated offences include imprisonment for up to five years, fines of up to $220,000 for an individual and up to $1.1 million for a corporation. Pursuant to s 188 in the case of corporate offenders, it is sufficient that conduct engaged in by a director, employee or agent of the corporation was within the scope of their actual or apparent authority and that the director, employee or agent had the relevant state of mind. The corporation is then deemed to have engaged in such conduct unless the corporation establishes that it took reasonable precautions and exercised due diligence to avoid the conduct.
In the Australian Capital Territory and New South Wales these can result in imprisonment for up to two years as well as a fine. The other jurisdictions only have fines as possible penalties.
Marsh v Baxter [2014] WASC 187 [216–218]. However, following the plaintiffs’ failure to collect the material or allow others to do it for them until six months after its arrival, eight volunteer GM canola plants eventually grew on the plaintiffs’ land. [138], [438] and [669].
‘17% of respondents stating that they could explain [genome editing] to a friend, 39% stating that they had heard of it but knew little or nothing about it, and another 39% stating that they had never heard of it.’ McCormack and Mercer (2017), p. 21.